BACE1 and Alzheimer disease: In patients with MCI, the expression level and activity of BACE1 are elevated, higher than those in healthy controls and AD patients, implying that BACE1, and possibly BACE1AS, might be used to differentiate between MCI and AD, offering potential for understanding and diagnosing early pathological changes related to vascular cognitive impairment [134].